| 1 | you hear about us? | | | | | | | 2 | 0.44% |
| 2 | did you hear about | | | | | | | 2 | 0.44% |
| 3 | diagnostics whats your geneiq? | | | | | | | 2 | 0.44% |
| 4 | intelligent diagnostics whats your | | | | | | | 2 | 0.44% |
| 5 | treatment decisions and improve | | | | | | | 2 | 0.44% |
| 6 | decisions and improve patient | | | | | | | 2 | 0.44% |
| 7 | and improve patient wellness | | | | | | | 2 | 0.44% |
| 8 | geneiq is a clia | | | | | | | 1 | 0.22% |
| 9 | molecular diagnostics laboratory specializing | | | | | | | 1 | 0.22% |
| 10 | certified molecular diagnostics laboratory | | | | | | | 1 | 0.22% |
| 11 | cola certified molecular diagnostics | | | | | | | 1 | 0.22% |
| 12 | and cola certified molecular | | | | | | | 1 | 0.22% |
| 13 | testing geneiq is a | | | | | | | 1 | 0.22% |
| 14 | realtime reverse transcriptasepolymerase chain | | | | | | | 1 | 0.22% |
| 15 | diagnostic testing geneiq is | | | | | | | 1 | 0.22% |
| 16 | molecular diagnostic testing geneiq | | | | | | | 1 | 0.22% |
| 17 | in molecular diagnostic testing | | | | | | | 1 | 0.22% |
| 18 | leader in molecular diagnostic | | | | | | | 1 | 0.22% |
| 19 | a leader in molecular | | | | | | | 1 | 0.22% |
| 20 | geneiq a leader in | | | | | | | 1 | 0.22% |
| 21 | is geneiq a leader | | | | | | | 1 | 0.22% |
| 22 | partner with us who | | | | | | | 1 | 0.22% |
| 23 | medication partner with us | | | | | | | 1 | 0.22% |
| 24 | diagnostics laboratory specializing in | | | | | | | 1 | 0.22% |
| 25 | transcriptasepolymerase chain reaction rtpcr | | | | | | | 1 | 0.22% |
| 26 | reverse transcriptasepolymerase chain reaction | | | | | | | 1 | 0.22% |
| 27 | in pharmacogenomic testing and | | | | | | | 1 | 0.22% |
| 28 | transmitted pathogens as well | | | | | | | 1 | 0.22% |
| 29 | sexually transmitted pathogens as | | | | | | | 1 | 0.22% |
| 30 | and sexually transmitted pathogens | | | | | | | 1 | 0.22% |
| 31 | urinary and sexually transmitted | | | | | | | 1 | 0.22% |
| 32 | respiratory urinary and sexually | | | | | | | 1 | 0.22% |
| 33 | for respiratory urinary and | | | | | | | 1 | 0.22% |
| 34 | and infectious disease testing | | | | | | | 1 | 0.22% |
| 35 | testing and infectious disease | | | | | | | 1 | 0.22% |
| 36 | pharmacogenomic testing and infectious | | | | | | | 1 | 0.22% |
| 37 | innovator in pharmacogenomic testing | | | | | | | 1 | 0.22% |
| 38 | the right medication partner | | | | | | | 1 | 0.22% |
| 39 | metroplex is a leading | | | | | | | 1 | 0.22% |
| 40 | dallas metroplex is a | | | | | | | 1 | 0.22% |